Walleye Capital LLC Protagonist Therapeutics, Inc Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$21.79 - $32.15 $1.12 Million - $1.65 Million	-51,312 Reduced 27.67%	134,114 $3.88 Million
Q4 2023 Feb 14, 2024	BUY	$14.05 - $23.44 $725,120 - $1.21 Million	51,610 Added 38.57%	185,426 $4.25 Million
Q3 2023 Nov 21, 2023	SELL	$16.68 - $23.66 $119,278 - $169,192	-7,151 Reduced 5.07%	133,816 $2.23 Million
Q3 2023 Nov 14, 2023	BUY	$16.68 - $23.66 $1.47 Million - $2.09 Million	88,306 Added 167.69%	140,967 $2.35 Million
Q2 2023 Aug 14, 2023	SELL	$18.02 - $29.36 $1.35 Million - $2.19 Million	-74,709 Reduced 58.66%	52,661 $1.45 Million
Q1 2023 May 15, 2023	SELL	$10.78 - $25.38 $4.28 Million - $10.1 Million	-396,932 Reduced 75.71%	127,370 $2.93 Million
Q4 2022 Feb 14, 2023	BUY	$7.36 - $11.17 $3.1 Million - $4.71 Million	421,359 Added 409.31%	524,302 $5.72 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $11.71 $1.21 Million - $1.81 Million	-154,414 Reduced 60.0%	102,943 $868,000
Q2 2022 Aug 08, 2022	BUY	$7.06 - $25.52 $1.58 Million - $5.72 Million	223,967 Added 670.76%	257,357 $2.04 Million
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $1.51 Million - $2.33 Million	-64,608 Reduced 65.93%	33,390 $791,000
Q4 2021 Mar 03, 2022	BUY	$17.63 - $37.1 $1.55 Million - $3.26 Million	87,882 Added 868.74%	97,998 $3.35 Million
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $131,002 - $502,664	10,116 New	10,116 $179,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.